YTEN on NASDAQ

Yield10 Bioscience

Agricultural Science Company

Yield10 Bioscience (formerly Metabolix, Inc.) is a company developing new technologies to achieve improvements in crop yield to enhance global food security.3 From Wikipedia, CC BY-SA 4.0

Price unavailable

Last updated Oct 16, 2026.

Overview

1992Founded1

Compare with ESG Inc., Agroz Inc. or ORIENTAL RISE HOLDINGS Ltd, or pick any stock.

  • TickerYTEN on NASDAQ1
  • IndustryAgricultural Production-Crops1
  • HeadquartersCambridge1
  • Websitewww.yield10bio.com
  • Listed onNasdaq (MBLX), Nasdaq (YTEN)1
  • Incorporated inDE4
  • Business address19 Presidential Way, Suite 201, Woburn, Ma 018014
  • Filer categoryNon-accelerated filer, Smaller reporting company4

Yield10 Bioscience (formerly Metabolix, Inc.) is a company developing new technologies to achieve improvements in crop yield to enhance global food security.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

-24028.3%Operating margin6
-24091.7%Net margin6
-86.7%Revenue growth, 20236
-$10.1MFree cash flow6

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Selling, general and admin100¢$6.2M

Out of $60.0K in revenue.6 The company lost money this year.

Financial statements

Revenue78910116$60.0K in 2023−94% since 2017
0$250.0K$500.0K$750.0K$1.0M2017: $944.0K$944.0K20172018: $556.0K$556.0K2018−41%2019: $806.0K$806.0K2019+45%2020: $799.0K$799.0K2020−1%2021: $614.0K$614.0K2021−23%2022: $450.0K$450.0K2022−27%2023: $60.0K$60.0K2023−87%
Operating income78910116-$14.4M in 2023+55% since 2017
-$15.0M-$10.0M-$5.0M02017: -$9.3M-$9.3M20172018: -$9.3M-$9.3M2018+0%2019: -$8.6M-$8.6M2019−8%2020: -$9.6M-$9.6M2020+12%2021: -$11.7M-$11.7M2021+22%2022: -$13.5M-$13.5M2022+15%2023: -$14.4M-$14.4M2023+7%
Net income78910116-$14.5M in 2023+54% since 2017
-$15.0M-$10.0M-$5.0M02017: -$9.4M-$9.4M20172018: -$9.2M-$9.2M2018−2%2019: -$13.0M-$13.0M2019+41%2020: -$10.2M-$10.2M2020−21%2021: -$11.0M-$11.0M2021+8%2022: -$13.6M-$13.6M2022+23%2023: -$14.5M-$14.5M2023+7%
Fiscal year2017201820192020202120222023
Revenue$944.0K7$556.0K8$806.0K9$799.0K10$614.0K11$450.0K6$60.0K6
Cost of revenue
Selling, general and admin$5.6M7$5.1M8$4.6M9$5.0M10$6.1M11$6.2M6$6.2M6
Operating income-$9.3M7-$9.3M8-$8.6M9-$9.6M10-$11.7M11-$13.5M6-$14.4M6
Income tax$014$08-$254.0K9$56.0K10$36.0K11$156.0K6$06
Net income-$9.4M7-$9.2M8-$13.0M9-$10.2M10-$11.0M11-$13.6M6-$14.5M6
Earnings per share-$3.2914-$4.3010-$2.3311-$2.766-$1.826
Earnings per share (diluted)-$4.3010-$2.3311-$2.766-$1.826

Compare Yield10 Bioscience with another company

The story

Founded by Anthony J Sinskey in 1992.1

Founded in 1992, with the help of a licensing agreement with Massachusetts Institute of Technology (MIT), Metabolix, Inc. is a bioscience company with headquarters in Cambridge, Massachusetts. Metabolix provides sustainable solutions to the plastic, chemical and energy industries. Oliver Peoples, Ph.D., and Anthony Sinskey, Ph.D., co-founded Metabolix after work at the (MIT) that identified the elementary methods and means for engineering polyhydroxyalkanoates production in plants and bacteria, thus making them biodegradable.

In early 2017, Metabolix became Yield10 Bioscience, its crop research program.

In 2024, Yield10 Biosciences filed for Chapter 11 bankruptcy protection, listing assets and liabilities between $1 million and $10 million.

From Wikipedia’s article on Yield10 Bioscience, shared under CC BY-SA 4.0.5

Leadership

Who has led Yield10 Bioscience, and when. Pick a name to see everywhere that person has worked.

Products and brands

Crop technologies

The centerpiece of the Metabolix's plant technology is polyhydroxybutyrate (PHB), the simplest member of the broad polyhydroxyalkanoate (PHA) family of biopolymers. They have worked with switchgrass, camelina, sugarcane, as well as tobacco.

In 2009, Metabolix completed a field trial producing PHA in a tobacco crop.

In 2012, Metabolix secured an ARPA-E grant to improve productivity of biofuel production in plants, specifically camelina.

In 2011, Metabolix was awarded a $6.0 million grant to produce PHB in switchgrass and to develop methods to thermally convert the PHB-containing switchgrass to crotonic acid and a higher density residual biomass fraction for production of biofuel.

Read the full text

In 2017, Yield10 participated in a Department of Energy program to help boost Camelina oilseed.

C3

C3 is the most common form of photosynthesis, existing in most crops suitable for human consumption, including wheat, canola, soybean and rice.

In 2019 Yield10 announced results from its 2018 field test, claiming that its C3003 gene trait showed an 11% increase in seed yield among canola crops, when compared to control plants. Similarly, C3003 met its objectives for soybean yield, and showed an increase in Camelina.

C4

C4 photosynthesis plants, like corn and sugar cane, possess a more complex system of metabolic pathways.

In 2018, Yield reported promising results for its C3004 gene trait in Camelina lines, following growth chamber studies.

CRISPR

Yield10 has also commenced development of CRISPR-enabled technology to impact crop yield. The company received a nonregulated status letter from the USDA-APHIS Biotechnology Regulatory Services (BRS) acknowledging that its camelina line has had a gene disrupted using CRISPR/Cas9 gene editing technology, resulting in the desired phenotype.

PHA-based Biomaterials

In 2019, Yield10 filed a U.S. Patent application for new technology enabling low-cost production of PHA-based biomaterials, knowing for their use in water treatment to remove nitrogen and phosphates, to maintain the viability and vigor of Camelina seed.

From Wikipedia’s article on Yield10 Bioscience, shared under CC BY-SA 4.0.5

Subsidiaries and ownership

Owners

  • Fidelity Investments

From Wikidata.1

Former names

  • METABOLIX, INC.Aug 10, 2006 to Jan 6, 20174
  • METABOLIX INCApr 25, 2002 to Jul 14, 20064

Timeline

  1. Nov 10, 2006Went public Listed on NASDAQ1
  2. 1992Founded Founded1

Recent filings

  1. Dec 6, 20248-K
  2. Nov 22, 20248-K
  3. Nov 12, 20248-K
  4. Oct 31, 20248-K
  5. Oct 3, 20248-K
  6. Sep 9, 20248-K
  7. Aug 20, 20244
  8. Aug 19, 20244 OWNERSHIP DOCUMENT
  9. Aug 19, 20244 OWNERSHIP DOCUMENT
  10. Aug 19, 20244 OWNERSHIP DOCUMENT
  11. Aug 14, 202410-Q
  12. Jul 23, 20248-K
  13. Jul 17, 20248-K
  14. Jun 12, 20248-K
  15. Jun 10, 20248-K

Every filing from the last three years, summarized. The full record is on SEC EDGAR.2